SOCS3 and cancer: Tests of predicted functional polymorphisms in HNSCC for SOCS3, have been conflicting; rs2280148 located at the 3′-untranslated region, indicated a predicted increase in the risk for this cancer, while rs8064821 located in the promoter region was associated with an decreased risk (118).